CNS, oncology and HIV clinical trials: Current trends and future prospects

Phil Collis, Gordon McVie

Research output: Contribution to journalArticlepeer-review


Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are that CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.

Original languageEnglish
Pages (from-to)74-77
Number of pages4
JournalEBR - European Biopharmaceutical Review
Issue numberSPRING
Publication statusPublished - Mar 2004

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'CNS, oncology and HIV clinical trials: Current trends and future prospects'. Together they form a unique fingerprint.

Cite this